These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32544924)

  • 1. Intrathecal chemotherapy-associated cerebral vasospasm in children with hematologic malignancies.
    Sun LR; Ziai W; Brown P; Torriente AG; Cooper S; Gottesman RF; Felling RJ
    Pediatr Res; 2021 Mar; 89(4):858-862. PubMed ID: 32544924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Cerebral Vasospasm and Childhood Arterial Ischemic Stroke After Intrathecal Cytarabine.
    Tibussek D; Natesirinilkul R; Sun LR; Wasserman BA; Brandão LR; deVeber G
    Pediatrics; 2016 Feb; 137(2):e20152143. PubMed ID: 26787046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.
    Pound CM; Keene DL; Udjus K; Humphreys P; Johnston DL
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):183-6. PubMed ID: 17356399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse cerebral vasospasm with infarct after intrathecal cytarabine in childhood leukemia.
    Yoon JH; Yoon JY; Park HJ; Son MH; Kim SH; Kim W; Kim HJ; Lee SH; Park BK
    Pediatr Int; 2014 Dec; 56(6):921-924. PubMed ID: 25521979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm.
    Henderson RD; Rajah T; Nicol AJ; Read SJ
    Neurology; 2003 Jan; 60(2):326-8. PubMed ID: 12552054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients.
    Olmos-Jiménez R; Díaz-Carrasco MS; Galera-Miñarro A; Pascual-Gazquez JF; Espuny-Miró A
    Int J Clin Pharm; 2017 Feb; 39(1):126-132. PubMed ID: 27933487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
    Kwong YL; Yeung DY; Chan JC
    Ann Hematol; 2009 Mar; 88(3):193-201. PubMed ID: 19050889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: A comparative randomized double-blind controlled trial.
    Ruktrirong J; Traivaree C; Monsereenusorn C; Photia A; Lertvivatpong N; Rujkijyanont P
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29002. PubMed ID: 33754455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of collateralization predicting symptomatic cerebral vasospasm among pediatric patients: correlations among angiography, transcranial Doppler ultrasonography, and clinical findings.
    Moftakhar P; Cooke DL; Fullerton HJ; Ko NU; Amans MR; Narvid JA; Dowd CF; Higashida RT; Halbach VV; Hetts SW
    J Neurosurg Pediatr; 2015 Mar; 15(3):282-90. PubMed ID: 25555113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
    Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
    Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution.
    Suarez JI; Qureshi AI; Yahia AB; Parekh PD; Tamargo RJ; Williams MA; Ulatowski JA; Hanley DF; Razumovsky AY
    Crit Care Med; 2002 Jun; 30(6):1348-55. PubMed ID: 12072693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of vasospasm in children with moderate-to-severe traumatic brain injury.
    O'Brien NF; Maa T; Yeates KO
    Crit Care Med; 2015 Mar; 43(3):674-85. PubMed ID: 25479116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar herniation after intrathecal chemotherapy including cytosine arabinoside in a boy with T acute lymphoblastic leukemia.
    Legrand F; Dorgeret S; Saizou C; Duval M; Vilmer E
    Leukemia; 2002 Dec; 16(12):2454-5. PubMed ID: 12454752
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.
    Benesch M; Siegler N; Hoff Kv; Lassay L; Kropshofer G; Müller H; Sommer C; Rutkowski S; Fleischhack G; Urban C
    Anticancer Drugs; 2009 Oct; 20(9):794-9. PubMed ID: 19617818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review protocol.
    Stuart D; Christian R; Uschmann H
    JBI Database System Rev Implement Rep; 2017 Mar; 15(3):628-637. PubMed ID: 28267024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accidental overdose of intrathecal cytarabine in children.
    Thienprayoon R; Heym KM; Pelfrey L; Bowers DC
    Ann Pharmacother; 2013 May; 47(5):e24. PubMed ID: 23606548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.